Primary dose-dense epirubicin/cyclophosphamide→docetaxel in breast cancer: preliminary results

被引：0
|
作者：
Cocciolone, V. [1 ]
Cannita, K. [1 ]
Bruera, G. [1 ]
Bafile, A. [2 ]
Coletti, G. [3 ]
Resta, V. [2 ]
Ciccozzi, A. [4 ]
Dalmas, A. [3 ]
Ficorella, C. [1 ]
Ricevuto, E. [1 ]
机构：
[1] Univ Aquila, S Salvatore Hosp, Med Oncol, I-67100 Laquila, Italy
[2] S Salvator Hosp, Breast Unit, I-67100 Laquila, Italy
[3] S Salvator Hosp, Pathol Anat, I-67100 Laquila, Italy
[4] S Salvator Hosp, Breast Radiol, I-67100 Laquila, Italy
来源：
BREAST | 2015年 / 24卷
关键词：
D O I：
10.1016/S0960-9776(15)70252-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P218
引用
收藏
页码：S100 / S101
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophosphamide followed by docetaxel in primary breast cancer.
    Cramer, EM
    Moers, C
    Zarghooni, V
    Mallmann, P
    Warm, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 82S - 82S
  • [2] Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide → dose-dense docetaxel
    Cocciolone, V.
    Tessitore, A.
    Ricevuto, E.
    Mastroiaco, V.
    Rinaldi, L.
    Paradisi, S.
    Irelli, A.
    Sidoni, T.
    Dal Mas, A.
    Coletti, G.
    Ciccozzi, A.
    Resta, V.
    Bafile, A.
    Alesse, E.
    Ficorella, C.
    Cannita, K.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S124 - S124
  • [3] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer
    Grassadonia, Antonino
    Cianchetti, Ettore
    Ficorella, Corrado
    Angelucci, Domenico
    Grossi, Simona
    Ricevuto, Enrico
    Zilli, Marinella
    Tinari, Nicola
    Natoli, Clara
    Iacobelli, Stefano
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 97 - 97
  • [4] Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer
    Mirzaei, Hamid Reza
    Rasekh, Parisa Sabet
    Nasrollahi, Fatemeh
    Rasekh, Parto Sabet
    Tirabad, Zahra Akbari
    RezaMoein, Hamid
    Pour, Taban Ghaffari
    Hajian, Parastoo
    [J]. INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
  • [5] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophoshamid followed by docetaxel in primary breast cancer
    Cramer, EM
    Moers, C
    Zarghooni, V
    Bosse, K
    Mallmann, P
    Warm, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S231 - S231
  • [6] Preoperative dose-dense sequential chemotherapy of epirubicin/ cyclophosphamide followed by docetaxellcapecitabine in patients with early breast cancer: preliminary results
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 158 - 158
  • [7] Preoperative dose-dense sequential chemotherapy of epirubicin/cyclophosphamide followed by docetaxel/capecitabine in patients with breast cancer.
    Natoli, C.
    Cianchetti, E.
    Ficorella, C.
    Angelucci, D.
    Grossi, S.
    Noccioli, P.
    Ricevuto, E.
    Grassadonia, A.
    Zilli, M.
    Di Giacobbe, A.
    Rispoli, A., I
    Tinari, N.
    Iacobelli, S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S150 - S150
  • [8] Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible
    Dang, Chau
    D'Andrea, Gabriella
    Lake, Diana
    Sugarman, Steve
    Fornier, Monica
    Moynahan, Mary Ellen
    Gilewski, Theresa
    Hurria, Arti
    Mills, Nancy
    Troso-Sandoval, Tiffany
    George, Roshini
    Robson, Mark
    Dickler, Maura
    Smith, Karen
    Panageas, Katherine S.
    Norton, Larry
    Hudis, Clifford A.
    [J]. CLINICAL BREAST CANCER, 2008, 8 (05) : 418 - 424
  • [9] Dose-dense docetaxel and epirubicine combination in advanced breast cancer: Preliminary results.
    Laurence, V
    Ben Merabet, F
    Cottu, PH
    Cuvier, C
    Espie, M
    Marty, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 28 - 28
  • [10] Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients
    Sanna, G.
    Pestrin, M.
    Zafarana, E.
    Biagioni, C.
    Cavaciocchi, D.
    Turner, N.
    Di Leo, A.
    Biganzoli, L.
    [J]. BREAST, 2013, 22 (05): : 926 - 932
12345